[The efficacy of intraventricularly administered vancomycin in the case of central nervous system infection caused by

Sławomir L Czaban1, Wojciech J Lebkowski, Jacek P Krajewski

  • 1Kliniki Anestezjologii i Intensywnej Terapii, Akademii Medycznej w Białymstoku.

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|February 28, 2003
PubMed

Insights

Intraventricular Vancomycin effectively treated cerebro-meningitis caused by Enterococcus faecalis when intravenous therapy failed. This approach bypasses the blood-brain barrier for direct antibiotic delivery to the cerebrospinal fluid (CSF).

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Pharmacology

Background:

  • Subarachnoid hemorrhage with intraventricular bleeding can lead to cerebro-meningitis.
  • Enterococcus faecalis, a pathogen resistant to standard intravenous glycopeptide antibiotics, can cause severe infections.
  • The blood-brain barrier often limits antibiotic penetration into the cerebrospinal fluid (CSF).

Observation:

  • A 40-year-old male patient presented with subarachnoid hemorrhage, intraventricular bleeding, and cerebro-meningitis due to Enterococcus faecalis.
  • Standard intravenous Vancomycin and Teicoplanin were ineffective, and the patient's condition worsened with sepsis.
  • Intraventricular Vancomycin (20 mg/day) was administered due to the ineffectiveness of intravenous therapy.

Findings:

  • The patient showed gradual recovery within two days of intraventricular Vancomycin administration.
  • Meningitis symptoms resolved, and cerebrospinal fluid (CSF) parameters normalized.
  • No bacterial growth was detected in blood serum or CSF, indicating successful eradication of Enterococcus faecalis.

Implications:

  • Intraventricular Vancomycin is an effective treatment for cerebro-meningitis, particularly when caused by resistant bacteria.
  • Direct intraventricular antibiotic administration can overcome blood-brain barrier limitations for treating central nervous system infections.
  • This therapeutic strategy offers an alternative for managing cerebro-meningitis when intravenous antibiotic efficacy is compromised or dose reduction is necessary.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...